Migalastat 123mg capsules
NHS hospitals in England used £58,089,245 of indicative cost of Migalastat 123mg capsules in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 9.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Migalastat 123mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Migalastat 123mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £28,883,084 |
| Salford Royal Nhs Foundation Trust | £21,500,774 |
| Cambridge Univ Hosp Nhs Foundation Trust | £4,523,078 |
| University College London Foundation Tr | £2,326,154 |
| Manchester University Nhs Ft | £323,077 |
The primary-care picture
Migalastat is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Migalastat medicine page.